Acadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc.

ACHCNYSE / NASDAQHealthcareMid cap

$34.60+$0.13 (+0.4%)

Last close · Data as of Nov 20, 2026

Market cap
$2.3B
P/E
-2.1x
EV / EBITDA
-6.5x
Revenue
$3.3B
Net margin
-33.3%
ROCE
7.8%

+140.9% over the last year

Acadia Healthcare Company, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+10.1%
3M
+28.3%
6M
+43.7%
1Y
+140.9%
5Y
-44.1%

52-week range

Day change +$0.13 (+0.4%) from $34 to $35 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in ACHC, bought on each weekday since 2021.

News & filings

What Acadia Healthcare Company filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernThe company made a net loss of 1.1 billion US dollars in fiscal 2025.

Strengths (1)

  • The price is 26.0% above its 200-day average, and the 50-day average is above the 200-day.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

Sector
Healthcare
Shares outstanding
90.5M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$2.3B
P/E
-2.1x
P/B
1.2x
EV / EBITDA
-6.5x
EV / Sales
1.5x
P/S
0.7x
52-week high
$38.80
52-week low
$11.68

Profitability

Operating margin
11.7%
Net margin
-33.3%
EBITDA margin
-22.3%
ROE
-56.6%
ROCE
7.8%
ROA
-20.0%
Asset turnover
0.60

Growth

Revenue
$3.3B
Revenue growth, 1Y
5.0%
Revenue CAGR, 3Y
8.3%
Net profit growth, 1Y
-531.4%
Free cash flow
-$439.9M

Solvency

Current ratio
1.55
Debt / Equity
1.36
Debt / Assets
0.48
CFO / Net profit
-0.12
Cash / Market cap
5.7%

Where the revenue went

FY2025 ended in a loss, so the lines are listed rather than drawn as a flow.

LineFY2025
Revenue$3.3B
Cost of revenue$118.0M
Gross profit$3.2B
Operating expenses$2.8B
Selling, general and administrative$2.1B
Operating income$388.0M
Interest and other-$1.5B
Pretax income-$1.1B
Tax and other$36.8M
Net income-$1.1B

Revenue and net profit

Revenue grew 5.0% in FY2025; net profit is the dashed line.

Acadia Healthcare Company, Inc. revenue and net profit by fiscal year
Acadia Healthcare Company, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$2.6B$273.1M
FY2023$2.9B-$21.7M
FY2024$3.2B$255.6M
FY2025$3.3B-$1.1B

Cash flows

FY2025: $131.9M from operations, -$439.9M free after investment (dashed).

Acadia Healthcare Company, Inc. operating and free cash flow by fiscal year
Acadia Healthcare Company, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$380.6M$84.4M
FY2023$462.3M$38.2M
FY2024$129.7M-$560.7M
FY2025$131.9M-$439.9M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$3.3B+5.0%1Y
EBITDA
-$737.8M-221.4%1Y
Net profit
-$1.1B-531.4%1Y
Cash from operations
$131.9M+1.7%1Y
Free cash flow
-$439.9M
Revenue CAGR, 3Y
8.3%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$3.3B-$737.8M-$1.1B-$439.9M-56.6%+5.0%-531.4%

Monthly returns

Month-by-month returns of ACHC across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$5.5B
Liabilities$3.4B
Equity$2.1B
Paid-in capital$2.7B
Retained earnings-$765.8M
Minority interest$191.6M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; ACHC highlighted.

P/E against peers

ACHC has no positive P/E; the peer median is 12.8x.

Not shown (no positive earnings and no EV / Sales): Acadia Healthcare Company, Inc., Supernus Pharmaceuticals, Inc., Neogen Corporation.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Acadia Healthcare Company, Inc.ACHCthis company$2.3B-2.1x1.2x-56.6%-6.5x
Privia Health Group, Inc.PRVA$2.7B117.5x3.7x3.1%50.4x
Supernus Pharmaceuticals, Inc.SUPN$2.6B-67.3x2.4x-3.6%58.9x
TransMedics Group, Inc.TMDX$2.5B13.0x5.2x40.2%16.8x
Prestige Consumer Healthcare Inc.PBH$2.2B11.3x1.1x10.1%9.5x
LeMaitre Vascular, Inc.LMAT$2.1B37.0x5.4x14.7%25.3x
Select Medical Holdings CorporationSEM$2.0B14.0x1.2x8.6%9.2x
Neogen CorporationNEOG$2.0B-1.8x1.0x-52.7%-2.9x
ADMA Biologics, Inc.ADMA$1.8B12.6x3.9x30.8%9.3x
Peer median—12.8x3.0x9.3%13.1x

Year-to-date ROI

ACHC since 1 January, against earlier years.

Historical volatility

ACHC's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Acadia Healthcare Company, Inc. operating margin by fiscal year
Acadia Healthcare Company, Inc. operating margin by fiscal year
DateOperating margin
FY202217.9%
FY202317.5%
FY202416.6%
FY202511.7%
LineFY2025
Cost of revenueCost Of Revenue$118.0M
Gross profitGross Profit$3.2B
Operating expensesOperating Expense$2.8B
Other operating expensesOther Operating Expenses$553.3M
Depreciation and amortisationDepreciation And Amortization In Income Statement$189.3M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$189.3M
Rent expense supplementalRent Expense Supplemental$48.0M
Total expensesTotal Expenses$2.9B
Operating incomeOperating Income$388.0M
Pretax incomePretax Income-$1.1B

Learn while you research

Academy chapters picked for Acadia Healthcare Company, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  3. 03 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  4. 04 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →